Strategic Preferred Partnership with Fisher Healthcare
HNL Lab Medicine Announces Strategic Preferred Partnership with Fisher Healthcare
HNL Lab Medicine proudly announces a new Strategic Preferred Partnership with Fisher Healthcare, a part of Thermo Fisher Scientific and a national leader in the distribution of laboratory products. The goal of this relationship is to enhance laboratory efficiency, improve patient care, and address the ongoing challenges of the lab industry.
Warren Erdmann, Chief Operating Officer of HNL Lab Medicine, emphasized the significance of this collaboration, saying, “Partnering with Fisher Healthcare, which supplies the essential items that keep our lab running smoothly, is a huge advantage. They’re a local partner with employees from our community, located just 10 minutes away from our lab. This enhances our ability to receive items quickly and efficiently.”
This collaboration brings together two organizations with a shared dedication to providing patients with access to exceptional laboratory diagnostic services and patient care. Fisher Healthcare’s industry-leading distribution platform provides HNL Lab Medicine one-stop-shopping access to an unrivaled selection of cutting-edge laboratory, life sciences, and diagnostic technology that will enable HNL Lab Medicine to focus on operational excellence and clinical precision, so they are well-equipped to tackle the increasing challenges within the lab industry. HNL Lab Medicine’s and Fisher Healthcare’s joint efforts are aimed to foster innovation in the supply chain, elevate laboratory efficiency, and improve patient outcomes, all while continuing to raise the bar for service standards.
Fisher Healthcare shares the same commitment to excellence in laboratory distribution services. “The strategic agreement between Fisher Healthcare and HNL recognizes HNL’s expectations and the potential for mutual benefits associated with growing our relationship as we begin to negotiate a long-term agreement,” said Allen Harder, Regional Vice President, Fisher Healthcare.
The Strategic Preferred Partnership Agreement is grounded in three core pillars: delivering high-quality results, maintaining exceptional service to patients and providers, and promoting a financial model that supports continuous reinvestment in employees, facilities, and equipment. By aligning on this strategic agreement, HNL Lab Medicine and Fisher Healthcare are aiming to unite their core strengths — easier access to state-of-the-art technology and unmatched operational expertise — to deliver superior healthcare solutions in an ever-evolving market.
By signing this agreement, Fisher Healthcare becomes part of HNL Lab Medicine’s broader Strategic Preferred Partnerships Program, which focuses on creating long-term, mutually beneficial relationships with leading vendors to drive innovation, improve patient outcomes, and ensure sustainable growth.